Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer.

Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer. J Med Chem. 2017 02 23; 60(4):1325-1342.

View in: PubMed

subject areas

Animals
Antineoplastic Agents, Hormonal
Breast
Breast Neoplasms
Cell Line, Tumor
Drug Resistance, Neoplasm
Female
Humans
Mice, Nude
Models, Molecular
Neoplasms, Hormone-Dependent
Receptors, Estrogen
Selective Estrogen Receptor Modulators
Thiophenes

authors with profiles

Jiong Zhao